Europe Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others



Summary



GlobalData’s new report, “Europe Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others” provides key market data on the Europe Neurology Devices market – France, Germany, Italy, Spain and United Kingdom. The report provides value (USD million) data for all the market categories – CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.



Scope


- Countries covered include France, Germany, Italy, Spain and United Kingdom.
- Market size and company share data for Neurology Devices market categories – CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.
- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the market categories and countries.
- Global corporate-level profiles of key companies operating within the Europe Neurology Devices market..
- Key players covered include Medtronic, Inc., St. Jude Medical, Inc., Stryker Corporation, Corporation, B. Braun Melsungen AG, Accuray Incorporated, Cadwell Laboratories, Inc. and others.



Reasons to buy


- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Europe Neurology Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table Of Contents

Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 11
2 Introduction 13
2.1 What is This Report About? 13
3 Neurology Devices in Europe 14
3.1 Neurology Devices Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018 14
3.2 Neurology Devices, Europe, Overall Revenue ($m), USD Constant, 2004-2018 16
3.3 Neurology Devices, Europe, Company share (2010-2011) 23
4 Neurology Devices In Germany 25
4.1 Neurology Devices, Germany, Overall Revenue ($m), USD Constant, 2004-2018 25
4.2 Neurology Devices, Germany, Distribution Share (2010-2011) 31
4.2.1 CSF Management, Germany, Distribution Share (2010-2011) 31
4.2.2 Interventional Neurology, Germany, Distribution Share (2010-2011) 31
4.2.3 Neurological Diagnostic Equipment, Germany, Distribution Share (2010-2011) 32
4.2.4 Neurostimulation Devices, Germany, Distribution Share (2010-2011) 32
4.2.5 Neurosurgical Products, Germany, Distribution Share (2010-2011) 33
4.2.6 Radiosurgery, Germany, Distribution Share (2010-2011) 33
4.3 Neurology Devices, Germany, Company Share (2010-2011) 34
4.3.1 Neurology Devices, Germany, Company Share (2010-2011) 34
4.3.2 CSF Management, Germany, Company Share (2010-2011) 36
4.3.3 Interventional Neurology, Germany, Company Share (2010-2011) 38
4.3.4 Neurological Diagnostic Equipment, Germany, Company Share (2010-2011) 40
4.3.5 Neurostimulation Devices, Germany, Company Share (2010-2011) 42
4.3.6 Neurosurgical Products, Germany, Company Share (2010-2011) 43
4.3.7 Radiosurgery, Germany, Company Share (2010-2011) 44
5 Neurology Devices In France 45
5.1 Neurology Devices, France, Overall Revenue ($m), USD Constant, 2004-2018 45
5.2 Neurology Devices, France, Distribution Share (2010-2011) 51
5.2.1 CSF Management, France, Distribution Share (2010-2011) 51
5.2.2 Interventional Neurology, France, Distribution Share (2010-2011) 51
5.2.3 Neurological Diagnostic Equipment, France, Distribution Share (2010-2011) 52
5.2.4 Neurostimulation Devices, France, Distribution Share (2010-2011) 52
5.2.5 Neurosurgical Products, France, Distribution Share (2010-2011) 53
5.2.6 Radiosurgery, France, Distribution Share (2010-2011) 53
5.3 Neurology Devices, France, Company Share (2010-2011) 54
5.3.1 Neurology Devices, France, Company Share (2010-2011) 54
5.3.2 CSF Management, France, Company Share (2010-2011) 56
5.3.3 Interventional Neurology, France, Company Share (2010-2011) 58
5.3.4 Neurological Diagnostic Equipment, France, Company Share (2010-2011) 60
5.3.5 Neurostimulation Devices, France, Company Share (2010-2011) 62
5.3.6 Neurosurgical Products, France, Company Share (2010-2011) 63
5.4 Radiosurgery, France, Company Share (2010-2011) 64
6 Neurology Devices In United Kingdom 65
6.1 Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 65
6.2 Neurology Devices, United Kingdom, Distribution Share (2010-2011) 71
6.2.1 CSF Management, United Kingdom, Distribution Share (2010-2011) 71
6.2.2 Interventional Neurology, United Kingdom, Distribution Share (2010-2011) 71
6.2.3 Neurological Diagnostic Equipment, United Kingdom, Distribution Share (2010-2011) 72
6.2.4 Neurostimulation Devices, United Kingdom, Distribution Share (2010-2011) 72
6.2.5 Neurosurgical Products, United Kingdom, Distribution Share (2010-2011) 73
6.2.6 Radiosurgery, United Kingdom, Distribution Share (2010-2011) 73
6.3 Neurology Devices, United Kingdom, Company Share (2010-2011) 74
6.3.1 Neurology Devices, United Kingdom, Company Share (2010-2011) 74
6.3.2 CSF Management, United Kingdom, Company Share (2010-2011) 76
6.3.3 Interventional Neurology, United Kingdom, Company Share (2010-2011) 78
6.3.4 Neurological Diagnostic Equipment, United Kingdom, Company Share (2010-2011) 80
6.3.5 Neurostimulation Devices, United Kingdom, Company Share (2010-2011) 82
6.3.6 Neurosurgical Products, United Kingdom, Company Share (2010-2011) 83
6.3.7 Radiosurgery, United Kingdom, Company Share (2010-2011) 84
7 Neurology Devices In Italy 85
7.1 Neurology Devices, Italy, Overall Revenue ($m), USD Constant, 2004-2018 85
7.2 Neurology Devices, Italy, Distribution Share (2010-2011) 91
7.2.1 CSF Management, Italy, Distribution Share (2010-2011) 91
7.2.2 Interventional Neurology, Italy, Distribution Share (2010-2011) 91
7.2.3 Neurological Diagnostic Equipment, Italy, Distribution Share (2010-2011) 92
7.2.4 Neurostimulation Devices, Italy, Distribution Share (2010-2011) 92
7.2.5 Neurosurgical Products, Italy, Distribution Share (2010-2011) 93
7.2.6 Radiosurgery, Italy, Distribution Share (2010-2011) 93
7.3 Neurology Devices, Italy, Company Share (2010-2011) 94
7.3.1 Neurology Devices, Italy, Company Share (2010-2011) 94
7.3.2 CSF Management, Italy, Company Share (2010-2011) 96
7.3.3 Interventional Neurology, Italy, Company Share (2010-2011) 98
7.3.4 Neurological Diagnostic Equipment, Italy, Company Share (2010-2011) 100
7.3.5 Neurostimulation Devices, Italy, Company Share (2010-2011) 102
7.3.6 Neurosurgical Products, Italy, Company Share (2010-2011) 103
7.3.7 Radiosurgery, Italy, Company Share (2010-2011) 104
8 Neurology Devices In Spain 105
8.1 Neurology Devices, Spain, Overall Revenue ($m), USD Constant, 2004-2018 105
8.2 Neurology Devices, Spain, Distribution Share (2010-2011) 111
8.2.1 CSF Management, Spain, Distribution Share (2010-2011) 111
8.2.2 Interventional Neurology, Spain, Distribution Share (2010-2011) 111
8.2.3 Neurological Diagnostic Equipment, Spain, Distribution Share (2010-2011) 112
8.2.4 Neurostimulation Devices, Spain, Distribution Share (2010-2011) 112
8.2.5 Neurosurgical Products, Spain, Distribution Share (2010-2011) 113
8.2.6 Radiosurgery, Spain, Distribution Share (2010-2011) 113
8.3 Neurology Devices, Spain, Company Share (2010-2011) 114
8.3.1 Neurology Devices, Spain, Company Share (2010-2011) 114
8.3.2 CSF Management, Spain, Company Share (2010-2011) 116
8.3.3 Interventional Neurology, Spain, Company Share (2010-2011) 118
8.3.4 Neurological Diagnostic Equipment, Spain, Company Share (2010-2011) 120
8.3.5 Neurostimulation Devices, Spain, Company Share (2010-2011) 122
8.3.6 Neurosurgical Products, Spain, Company Share (2010-2011) 123
8.3.7 Radiosurgery, Spain, Company Share (2010-2011) 124
9 Overview of Key Companies in Europe Neurology Devices Market 125
9.1 Medtronic, Inc. 125
9.1.1 Company Overview 125
9.1.2 Share in the Europe Neurology Devices Market 125
9.2 St. Jude Medical, Inc. 126
9.2.1 Company Overview 126
9.2.2 Share in the Europe Neurology Devices Market 126
9.3 Stryker Corporation 127
9.3.1 Company Overview 127
9.3.2 Share in the Europe Neurology Devices Market 127
9.4 Accuray Incorporated 128
9.4.1 Company Overview 128
9.4.2 Share in the Europe Neurology Devices Market 128
9.5 B. Braun Melsungen AG 129
9.5.1 Company Overview 129
9.5.2 Share in the Europe Neurology Devices Market 129
9.6 DePuy, Inc. 130
9.6.1 Company Overview 130
9.6.2 Share in the Europe Neurology Devices Market 130
9.7 Cadwell Laboratories, Inc. 131
9.7.1 Company Overview 131
9.8 Covidien plc 131
9.8.1 Company Overview 131
9.9 Terumo Corporation 131
9.9.1 Company Overview 131
9.10 Cyberonics, Inc. 132
9.10.1 Company Overview 132
9.11 Integra LifeSciences Holdings Corporation 132
9.11.1 Company Overview 132
9.12 CareFusion Corporation 133
9.12.1 Company Overview 133
9.13 Christoph Miethke GmbH and Co. KG 133
9.13.1 Company Overview 133
9.14 Natus Medical Incorporated 134
9.14.1 Company Overview 134
9.15 Micromed S.p.A 134
9.15.1 Company Overview 134
9.16 Boston Scientific Corporation 135
9.16.1 Company Overview 135
9.17 Nihon Kohden Corporation 135
9.17.1 Company Overview 135
9.18 Elekta AB 136
9.18.1 Company Overview 136
9.19 Sophysa S.A. 136
9.19.1 Company Overview 136
9.20 KARL STORZ GmbH and Co. KG 136
9.20.1 Company Overview 136
10 Neurology Devices Market Pipeline Products 137
11 Financial Deals Landscape 141
11.1 Acquisition 141
11.1.1 Elekta Completes Acquisition Of Nucletron For $523 Million 141
11.2 Partnerships 143
11.2.1 Regent Surgical Enters Into Joint Venture Agreement With Hermitage Medical, Neurosurgery Ireland And Accelitech For Neurosurgical Center 143
11.2.2 GE Healthcare Enters Into A Distribution Agreement With KC BioMedix 144
12 Recent Developments 145
12.1 Strategy And Business Planning 145
12.1.1 Feb 09, 2012: Zynex Forms European Subsidiary 145
12.1.2 Dec 19, 2011: Medical Centers Worldwide Adopt Both Accuray's CyberKnife And TomoTherapy Systems 145
12.1.3 Oct 27, 2011: Ambu Announces Organizational Re-Structuring As Part Of Strategy 145
12.1.4 Oct 13, 2011: Unisense Establishes US Headquarter 146
12.2 Research And Development 146
12.2.1 Mar 21, 2012: Index Ventures Launches New €150m Life Sciences Fund With Investments From GSK And Janssen 146
12.2.2 Nov 08, 2011: Bright Light Into Ear Canal Treats Seasonal Depression Effectively In Two Clinical Trials Presented By Valkee And University of Oulu 147
12.2.3 Aug 11, 2011: Valkee And University of Oulu Presents New Findings On Human Brain’s Photosensitivity At Scandinavian Physiology Society Annual Meeting 2011 148
12.3 Legal and Regulatory 148
12.3.1 Sep 26, 2011: Occlutech CEO Wins Patent Lawsuit By St Jude-AGA Medical 148
12.4 Government and Public Interest 149
12.4.1 Apr 23, 2012: New Technique May Help Severely Damaged Nerves Regrow And Restore Function: University of Sheffield 149
12.4.2 Feb 18, 2012: New EEG Shows How Brain Tracts Are Formed: Study 149
12.4.3 Jan 27, 2012: Elekta Demonstrates Comprehensive Range Of Cancer Management Solutions At 2012 Arab Health Congress And Exhibition 150
12.4.4 Jan 10, 2012: Fusion Plasma Research Helps Neurologists To Hear Above The Noise 151
12.4.5 Dec 15, 2011: Finland Researchers Develops Decision Support Tool To Help Diagnose Alzheimer’s Disease 152
12.5 Product News 153
12.5.1 Sep 26, 2011: Elekta To Showcase Its Products At 2011 ASTRO Meeting In Florida 153
13 Appendix 154
13.1 Definitions of Markets Covered in the Report 155
13.1.1 Neurology Devices 155
13.2 Research Methodology 156
13.3 Secondary Research 156
13.4 Primary Research 157
13.5 Models 157
13.6 Forecasts 157
13.7 Expert Panels 158
13.8 GlobalData Consulting 158
13.9 Currency Conversion 158
13.10 Contact Us 158
13.11 Disclaimer 159
List of Tables

1.1 List of Tables
Table 1: Neurology Devices, Cross Country Comparison, Revenue ($m),USD Constant, 2004-2018 15
Table 2: Neurology Devices, Europe, Overall Revenue ($m), USD Constant, 2004-2018 17
Table 3: Neurology Devices, Europe, Cross-Category Analysis, 2004-2018 18
Table 4: Neurology Devices, Europe, Overall Revenue ($m), USD Constant, Historic, 2004-2011 20
Table 5: Neurology Devices, Europe, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 22
Table 6: Neurology Devices, Europe, Company share by Revenue ($m), USD Constant, 2010-2011 24
Table 7: Neurology Devices, Germany, Overall Revenue ($m), USD Constant, 2004-2018 26
Table 8: Neurology Devices, Germany, Overall Revenue ($m), USD Constant, Historic, 2004-2011 28
Table 9: Neurology Devices, Germany, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 30
Table 10: CSF Management, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011 31
Table 11: Interventional Neurology, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011 31
Table 12: Neurological Diagnostic Equipment, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011 32
Table 13: Neurostimulation Devices, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011 32
Table 14: Neurosurgical Products, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011 33
Table 15: Radiosurgery, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011 33
Table 16: Neurology Devices, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011 35
Table 17: CSF Management, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011 37
Table 18: Interventional Neurology, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011 39
Table 19: Neurological Diagnostic Equipment, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011 41
Table 20: Neurostimulation Devices, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011 42
Table 21: Neurosurgical Products, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011 43
Table 22: Radiosurgery, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011 44
Table 23: Neurology Devices, France, Overall Revenue ($m), USD Constant, 2004-2018 46
Table 24: Neurology Devices, France, Overall Revenue ($m), USD Constant, Historic, 2004-2011 48
Table 25: Neurology Devices, France, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 50
Table 26: CSF Management, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011 51
Table 27: Interventional Neurology, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011 51
Table 28: Neurological Diagnostic Equipment, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011 52
Table 29: Neurostimulation Devices, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011 52
Table 30: Neurosurgical Products, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011 53
Table 31: Radiosurgery, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011 53
Table 32: Neurology Devices, France, Company Share, USD Constant, (2010-2011) 55
Table 33: CSF Management, France, Company Share by Revenue ($m), USD Constant, 2010-2011 57
Table 34: Interventional Neurology, France, Company Share by Revenue ($m), USD Constant, 2010-2011 59
Table 35: Neurological Diagnostic Equipment, France, Company Share by Revenue ($m), USD Constant, 2010-2011 61
Table 36: Neurostimulation Devices, France, Company Share by Revenue ($m), USD Constant, 2010-2011 62
Table 37: Neurosurgical Products, France, Company Share by Revenue ($m), USD Constant, 2010-2011 63
Table 38: Radiosurgery, France, Company Share by Revenue ($m), USD Constant, 2010-2011 64
Table 39: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 66
Table 40: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, Historic, 2004-2011 68
Table 41: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 70
Table 42: CSF Management, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 71
Table 43: Interventional Neurology, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 71
Table 44: Neurological Diagnostic Equipment, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 72
Table 45: Neurostimulation Devices, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 72
Table 46: Neurosurgical Products, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 73
Table 47: Radiosurgery, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 73
Table 48: Neurology Devices, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 75
Table 49: CSF Management, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 77
Table 50: Interventional Neurology, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 79
Table 51: Neurological Diagnostic Equipment, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 81
Table 52: Neurostimulation Devices, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 82
Table 53: Neurosurgical Products, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 83
Table 54: Radiosurgery, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 84
Table 55: Neurology Devices, Italy, Overall Revenue ($m), USD Constant, 2004-2018 86
Table 56: Neurology Devices, Italy, Overall Revenue ($m), USD Constant, Historic, 2004-2011 88
Table 57: Neurology Devices, Italy, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 90
Table 58: CSF Management, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011 91
Table 59: Interventional Neurology, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011 91
Table 60: Neurological Diagnostic Equipment, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011 92
Table 61: Neurostimulation Devices, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011 92
Table 62: Neurosurgical Products, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011 93
Table 63: Radiosurgery, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011 93
Table 64: Neurology Devices, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011 95
Table 65: CSF Management, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011 97
Table 66: Interventional Neurology, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011 99
Table 67: Neurological Diagnostic Equipment, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011 101
Table 68: Neurostimulation Devices, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011 102
Table 69: Neurosurgical Products, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011 103
Table 70: Radiosurgery, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011 104
Table 71: Neurology Devices, Spain, Overall Revenue ($m), USD Constant, 2004-2018 106
Table 72: Neurology Devices, Spain, Overall Revenue ($m), USD Constant, Historic, 2004-2011 108
Table 73: Neurology Devices, Spain, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 110
Table 74: CSF Management, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011 111
Table 75: Interventional Neurology, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011 111
Table 76: Neurological Diagnostic Equipment, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011 112
Table 77: Neurostimulation Devices, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011 112
Table 78: Neurosurgical Products, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011 113
Table 79: Radiosurgery, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011 113
Table 80: Neurology Devices, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011 115
Table 81: CSF Management, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011 117
Table 82: Interventional Neurology, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011 119
Table 83: Neurological Diagnostic Equipment, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011 121
Table 84: Neurostimulation Devices, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011 122
Table 85: Neurosurgical Products, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011 123
Table 86: Radiosurgery, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011 124
Table 87: Neurology Devices Market Pipeline Products 137
Table 88: Elekta Completes Acquisition Of Nucletron For $523 Million 141
Table 89: Regent Surgical Enters Into Joint Venture Agreement With Hermitage Medical, Neurosurgery Ireland And Accelitech For Neurosurgical Center 143
Table 90: GE Healthcare Enters Into A Distribution Agreement With KC BioMedix 144
List of Figures

1.2 List of Figures
Figure 1: Neurology Devices, Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018 14
Figure 2: Neurology Devices, Europe, Overall Revenue ($m), USD Constant, 2004-2018 16
Figure 3: Neurology Devices, Europe, Cross-Category Analysis, 2004-2018 18
Figure 4: Neurology Devices, Europe, Overall Revenue ($m), USD Constant, Historic, 2004-2011 19
Figure 5: Neurology Devices, Europe, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 21
Figure 6: Neurology Devices, Europe, Company share (%), 2011 23
Figure 7: Neurology Devices, Germany, Overall Revenue ($m), USD Constant, 2004-2018 25
Figure 8: Neurology Devices, Germany, Overall Revenue ($m), USD Constant, Historic, 2004-2011 27
Figure 9: Neurology Devices, Germany, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 29
Figure 10: Neurology Devices, Germany, Company Share (%), 2011 34
Figure 11: CSF Management, Germany, Company Share (%), 2011 36
Figure 12: Interventional Neurology, Germany, Company Share (%), 2011 38
Figure 13: Neurological Diagnostic Equipment, Germany, Company Share (%), 2011 40
Figure 14: Neurostimulation Devices, Germany, Company Share (%), 2011 42
Figure 15: Neurosurgical Products, Germany, Company Share (%), 2011 43
Figure 16: Neurology Devices, France, Overall Revenue ($m), USD Constant, 2004-2018 45
Figure 17: Neurology Devices, France, Overall Revenue ($m), USD Constant, Historic, 2004-2011 47
Figure 18: Neurology Devices, France, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 49
Figure 19: Neurology Devices, France, Company Share (%), 2011 54
Figure 20: CSF Management, France, Company Share (%), 2011 56
Figure 21: Interventional Neurology, France, Company Share (%), 2011 58
Figure 22: Neurological Diagnostic Equipment, France, Company Share (%), 2011 60
Figure 23: Neurostimulation Devices, France, Company Share (%), 2011 62
Figure 24: Neurosurgical Products, France, Company Share (%), 2011 63
Figure 25: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 65
Figure 26: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, Historic, 2004-2011 67
Figure 27: Neurology Devices, United Kingdom, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 69
Figure 28: Neurology Devices, United Kingdom, Company Share (%), 2011 74
Figure 29: CSF Management, United Kingdom, Company Share (%), 2011 76
Figure 30: Interventional Neurology, United Kingdom, Company Share (%), 2011 78
Figure 31: Neurological Diagnostic Equipment, United Kingdom, Company Share (%), 2011 80
Figure 32: Neurostimulation Devices, United Kingdom, Company Share (%), 2011 82
Figure 33: Neurosurgical Products, United Kingdom, Company Share (%), 2011 83
Figure 34: Radiosurgery, United Kingdom, Company Share (%), 2011 84
Figure 35: Neurology Devices, Italy, Overall Revenue ($m), USD Constant, 2004-2018 85
Figure 36: Neurology Devices, Italy, Overall Revenue ($m), USD Constant, Historic, 2004-2011 87
Figure 37: Neurology Devices, Italy, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 89
Figure 38: Neurology Devices, Italy, Company Share (%), 2011 94
Figure 39: CSF Management, Italy, Company Share (%), 2011 96
Figure 40: Interventional Neurology, Italy, Company Share (%), 2011 98
Figure 41: Neurological Diagnostic Equipment, Italy, Company Share (%), 2011 100
Figure 42: Neurostimulation Devices, Italy, Company Share (%), 2011 102
Figure 43: Neurosurgical Products, Italy, Company Share (%), 2011 103
Figure 44: Neurology Devices, Spain, Overall Revenue ($m), USD Constant, 2004-2018 105
Figure 45: Neurology Devices, Spain, Overall Revenue ($m), USD Constant, Historic, 2004-2011 107
Figure 46: Neurology Devices, Spain, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 109
Figure 47: Neurology Devices, Spain, Company Share (%), 2011 114
Figure 48: CSF Management, Spain, Company Share (%), 2011 116
Figure 49: Interventional Neurology, Spain, Company Share (%), 2011 118
Figure 50: Neurological Diagnostic Equipment, Spain, Company Share (%), 2011 120
Figure 51: Neurostimulation Devices, Spain, Company Share (%), 2011 122
Figure 52: Neurosurgical Products, Spain, Company Share (%), 2011 123
Figure 53: Medtronic, Inc., Company Share (%), Europe Neurology Devices Market, 2011 125
Figure 54: St. Jude Medical, Inc., Company Share (%), Europe Neurology Devices Market, 2011 126
Figure 55: Stryker Corporation, Company Share (%), Europe Neurology Devices Market, 2011 127
Figure 56: Accuray Incorporated, Company Share (%), Europe Neurology Devices Market, 2011 128
Figure 57: B. Braun Melsungen AG, Company Share (%), Europe Neurology Devices Market, 2011 129
Figure 58: DePuy, Inc., Company Share (%), Europe Neurology Devices Market, 2011 130
Companies Mentioned

Medtronic, Inc.
St. Jude Medical, Inc.
Stryker Corporation
Accuray Incorporated
B. Braun Melsungen AG
DePuy, Inc.
Cadwell Laboratories, Inc.
Covidien plc
Terumo Corporation
Cyberonics, Inc.
Integra LifeSciences Holdings Corporation
CareFusion Corporation

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Regenerative Medicine Market (Bone and Joint) (By Technology - By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products & Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013

Regenerative Medicine Market (Bone and Joint) (By Technology - By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products & Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013

  • $ 4 795
  • Industry report
  • July 2014
  • by Transparency Market Research

U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital ...

Regenerative Medicine Market (Bone and Joint) (By Technology - By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products...) - Global Industry Analysis, Size, Share, Growth, Trends & Forecast, 2013 - 2019

Regenerative Medicine Market (Bone and Joint) (By Technology - By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products...) - Global Industry Analysis, Size, Share, Growth, Trends & Forecast, 2013 - 2019

  • $ 4 795
  • Industry report
  • July 2014
  • by Transparency Market Research

U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital ...

Ablation Technologies Market (Applications: Cardiovascular, Gynecology, Pain Management, Oncology, Urology, Ophthalmology; Technologies: Radiofrequency, Light/Laser, Electrical, Ultrasound, Microwave, Cryotherapy) - Global Industry Analysis, Size, Share,

Ablation Technologies Market (Applications: Cardiovascular, Gynecology, Pain Management, Oncology, Urology, Ophthalmology; Technologies: Radiofrequency, Light/Laser, Electrical, Ultrasound, Microwave, Cryotherapy) - Global Industry Analysis, Size, Share,

  • $ 4 795
  • Industry report
  • July 2014
  • by Transparency Market Research

An ablation procedure is a minimally invasive process to remove unwanted tissue from the body by using various energy devices such as radiofrequency, microwave, ultrasound, electrical current, laser and ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.